Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 68 results for "gdufa"

Granules gains 5% on removal from list of arrears by USFDA

Granules today said all annual facility fees as required under GDUFA, was paid before due date. Money Control, 1 month ago

BPTF Calls for Changes to GDUFA

The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates, asked FDA at a June 15 public meeting to consider several changes to performance goals and the fee payment schedule prior to ...
 PharmTech.com2 months ago BPTF Seeks Changes in Performance Goals, Fee Payment Schedule in GDUFA Renegotiations  Biotechgate2 months ago
Pharma Letter

Feature: Indian pharma cos seek faster clearance as GDUFA I nears end

Indian pharma companies may finally be looking at a better rate of clearances from the US Food and Drug… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login , ...
 Pharma Letter1 month ago Drug firms bank on faster US approvals  Calcutta Telegraph2 months ago

FDA Tightens Screws on GDUFA Fee Scofflaws

The FDA has warned three generics makers for failing to pay GDUFA fees during the last three fiscal years. The companies —Syntho Pharmaceuticals of Farmingdale, N.Y., Sharon Bio-Medicine of Dehradun, Uttarakhand in India, and Wuxi Kaili ...
 FDA News1 month ago FDA, Generic Manufacturers Want Faster GDUFA Approvals  FDA News2 months ago Generics Industry Calls for Changes to GDUFA  PharmExec.com2 months ago

US generic drugmakers note shortfalls in FDA implementation of GDUFA

In a statement by Ralph Neas, president and chief executive of the US trade group the Generic Pharmaceutical… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login ...
 Pharma Letter2 months ago Statement by Ralph G. Neas, President and CEO, GPhA, on the June 15th FDA Public Meeting on GDUFA  Pharmacy Times2 months ago
Virtual Strategy Magazine

FDA Publishes FY 2016 Medical Device and Generic Drug User Fees

The U.S. FDA published medical device and generic drug user fee rates for FY 2016. Registrar Corp reports on the fees. Hampton, VA (PRWEB) August 05, 2015 In early August each year, the U.S. Food and Drug Administration (FDA) publishes various ...
 Virtual Strategy Magazine3 weeks ago
Med India

Generic Drug User FeeAbbreviated New Drug Application, Prior Approval Supplement, Drug Master File, Final Dosage Form Facility, and Active...

Generic Drug User FeeAbbreviated New Drug Application, Prior Approval Supplement, Drug Master File, Final Dosage Form Facility, and Active Pharmaceutical Ingredient Facility Fee Rates for Fiscal Year 2016 Notice. Citation: "80 FR 46015" ...
 Pharmacy Choice3 weeks ago Food and Drug Administration Warns Sharon Bio Medicine on Generic Drug-User Fee  Med India1 month ago
Money Control

FDA Issues Notice on Generic Drug User Fee-Abbreviated Application

Targeted News Service WASHINGTON, Aug. 2 The Department of Health & Human Services published the following notice in the Federal Register from the Food & Drug Administration: Generic Drug User Fee-Abbreviated New Drug Application, Prior ...
 Pharmacy Choice3 weeks ago USFDA issues warning letter to Sharon Bio-medicine  Money Control1 month ago US FDA asks Sharon Bio to pay user fee dues  Hindu Business Line1 month ago US Drug Regulator Issues Warning Letter to Sharon Bio-Medicine  NDTV Profit1 month ago
Financial Express

BSE Sensex surges 409 points led by banking, pharma stocks; NSE Nifty above 8,500

The benchmark BSE Sensex , NSE Nifty opened in green on Friday, thereby continuing Thursday's winning streak despite mixed global trends today. (Express Photo) The benchmark BSE Sensex rocketed 409 points at 28,114.56 on Friday on continued ...
 Financial Express3 weeks ago BSE Sensex ends 142 points up, Dr Reddy's stocks surge nearly 6%; NSE Nifty below 8,450  Financial Express4 weeks ago BSE Sensex ends 43.19 points down at 28,420.12; NSE Nifty reclaims 8,600  Financial Express1 month ago Live: Sensex recovers 87.74 points to end at 27,661.40  Livemint.com1 month ago

Roth Capital: Time To Buy IGI Labs, 2016 Could Be 'Breakout Year'

In a report published Friday, Roth Capital Partners analyst Scott R. Henry upgraded the rating on IGI Laboratories, Inc. (NYSE: IG) from Neutral to Buy, while raising the price target from $7 to $11. Analyst Scott R Henry cited "stabilization of ...
 Benzinga.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less